Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

Cancer Molecular Diagnostics 2019 - 2023: Markets, Strategies and Trends, Volume & Price Forecasts by Cancer Type and Country with Executive and Consultant Guides

Be the first to review this product

“Companion diagnostics and liquid biopsy drive market growth while lowering costs.....”

You can choose to pay by purchase order during checkout

Availability: In stock


* Required Fields

You can choose to pay by purchase order during checkout
Howe Sound Research

Digital downloads direct to your inbox within 24 hours.

First class customer service from our team of experts.

Pay by credit card or request an invoice

Product Description


Published November 14, 2018

Table of Contents

A market that just keeps on growing. Molecular diagnostics is positioned to directly benefit from the explosion in genomics knowledge. A range of dynamic trends are pushing market growth and company valuations, including:


  • Personalized medicine
  • Pharmacogenomics
  • Liquid biopsy
  • Emergence of new economies with large markets
  • Greater understanding of the role of genetic material in disease and health


Exciting technical developments especially in the area of pharmacogenics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage. 

The unit volumes of tests performed is presented. Use our pricing scenarios, or use your own.  Project your market share and your price to reliably generate revenue forecasts or understand your own current market share position.  Detailed market forecasts provide price, volume and revenue forecasts individually broken out by year for oncology testing.  

In addition customization work, breakouts for particular segments, assistance and support is included free of charge with every report. 

  • Hundreds of pages of information including a complete list of Current 2018 United States Medicare Fee Payment Schedules to help understand test pricing in detail
  • See lists of all current FDA Approved Molecular Diagnostic Tests
  • Make facilities planning decisions
  • Forecast demand for new testing regimes or technologies
  • Make research investment decisions
  • Based on extensive primary and secondary research, the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand
  • Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges
  • Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges


The report includes detailed breakouts for 18 Countries and 4 Regions.  A detailed breakout for any country in the world is available to purchasers of the report.

All report data is available in Excel format on request.



Mr. Greg Powell, B.SC., M.B.A is an experienced business and clinical professional.  He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping."  He has worked in laboratory testing and management for over 20 years.  Mr. Powell’s education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Additional Information

Additional Information

Publisher name Howe Sound Research
Format PDF
Page count 348
Publication date 14 Nov 2018
Table of contents

Table of Contents

Report sample

Sample data tables


Write Your Own Review

Only registered users can write reviews. Please, log in or register

Product Tags

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.